Axogen (AXGN) Asset Writedowns and Impairment (2016 - 2026)
Axogen (AXGN) recorded quarterly Asset Writedowns and Impairment of -$120000.0 in Q1 2026, down 385.71% quarter-over-quarter from $42000.0 in Q4 2025, and down 164.17% on a YoY basis from $187000.0 in Q1 2025.
Axogen (AXGN) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends
Axogen's Asset Writedowns and Impairment history runs 11 years deep, the most recent figure standing at -$120000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 164.17% year-over-year to -$120000.0; the TTM figure through Mar 2026 stood at $93000.0 (down 84.02% YoY), while the FY2025 annual figure was $400000.0, down 38.46% from the prior year.
- Asset Writedowns and Impairment was -$120000.0 for Q1 2026 at Axogen, down from $42000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $789000.0 in Q3 2023 to a low of -$120000.0 in Q1 2026.
- Historically, Asset Writedowns and Impairment has averaged $253882.4 across 5 years, with a median of $255000.0 in 2024.
- The sharpest annual moves came in 2023 and 2026: Asset Writedowns and Impairment soared 576.09% in 2023, then sank 164.17% in 2026.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $46000.0 in 2022, then jumped by 576.09% to $311000.0 in 2023, then tumbled by 85.21% to $46000.0 in 2024, then retreated by 8.7% to $42000.0 in 2025, then slumped by 385.71% to -$120000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at -$120000.0 (Q1 2026), $42000.0 (Q4 2025), and -$28000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120,000.00 |
| Mar 31, 2026 | -120,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |